Publicaciones (349) Publicaciones de RAFAEL BAÑARES CAÑIZARES

2023

  1. Afectación renal en la enfermedad hepática crónica avanzada. Síndrome hepatorrenal

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 82, pp. 4841-4849

  2. Akkermansia deficiency and mucin depletion are implicated in intestinal barrier dysfunction as earlier event in the development of inflammation in interleukin-10-deficient mice

    Frontiers in Microbiology, Vol. 13

  3. Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode

    Liver International, Vol. 43, Núm. 7, pp. 1548-1557

  4. An Economic Analysis of Transjugular Intrahepatic Portosystemic Covered Stent Shunt for Variceal Bleeding and Refractory Ascites in a Spanish Setting

    Advances in Therapy, Vol. 40, Núm. 7, pp. 3006-3020

  5. CT-derived liver and spleen volume accurately diagnose clinically significant portal hypertension in patients with hepatocellular carcinoma

    JHEP Reports, Vol. 5, Núm. 3

  6. Complicaciones agudas del paciente cirrótico. Ascitis, encefalopatía hepática y síndrome hepatorrenal

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 89, pp. 5269-5277

  7. Hemorragia digestiva en urgencias

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 89, pp. 5241-5247

  8. Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding

    Gut, Vol. 72, Núm. 4, pp. 749-758

  9. Implementation and impact of an antibiotic control program and multidrug-resistant bacterial colonization in a liver transplant unit

    Revista Espanola de Enfermedades Digestivas, Vol. 115, Núm. 7, pp. 357-361

  10. Lack of Cyclin E1 in hepatocytes aggravates ethanol-induced liver injury and hepatic steatosis in experimental murine model of acute and chronic alcohol-associated liver disease

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1869, Núm. 4

  11. Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome

    Transplantation, Vol. 107, Núm. 6, pp. 1330-1340

  12. Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis

    Hepatology (Baltimore, Md.), Vol. 77, Núm. 6, pp. 2052-2062

  13. Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis

    Cell death & disease, Vol. 14, Núm. 8, pp. 514

  14. Non-invasive candidate protein signature predicts hepatic venous pressure gradient reduction in cirrhotic patients after sustained virologic response

    Liver International, Vol. 43, Núm. 9, pp. 1984-1994

  15. Portal hypertension increases the risk of hepatic decompensation after 90Yttrium radioembolization in patients with hepatocellular carcinoma: a cohort study

    Therapeutic Advances in Gastroenterology, Vol. 16

  16. Pregnancy outcomes in patients with portal cavernoma: A case series study

    International Journal of Gynecology and Obstetrics, Vol. 163, Núm. 1, pp. 277-281

  17. Prognostic implications of systolic function in patients with cirrhosis

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 6, pp. 446-454

  18. Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on- chronic liver failure

    Journal of Hepatology, Vol. 79, Núm. 1, pp. 79-92

  19. Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD

    Liver International, Vol. 43, Núm. 9, pp. 1909-1919